Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (201-210 of 527) with videos related to

Pageof 53
Sort By:
Antiviral Therapy|February 17, 2007
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapyMing-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
Journal of Gastroenterology and Hepatology|March 23, 2007
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patientsLi-Po Lee, Chia-Yen Dai, Wan-Long Chuang, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre studyChia-Yen Dai, Tai-Chung Tseng, Grace Lai Hung Wong, et al.
Journal of Hepatology|December 26, 2009
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in TaiwanChia-Yen Dai, Chi-Kung Ho, Jee-Fu Huang, et al.
Scandinavian Journal of Infectious Diseases|April 11, 2009
Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNAYa-Yun Lin, Jee-Fu Huang, Shu-Fen Liu, et al.
JAMA Network Open|August 17, 2023
Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver DiseaseHuiyul Park, Eileen L Yoon, Takanori Ito, et al.
The Lancet. Gastroenterology & Hepatology|January 27, 2018
Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysisMarcus M Mücke, Lisa I Backus, Victoria T Mücke, et al.
Medicine|November 14, 2009
Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinomaJen-Eing Jeng, Huey-Ru Tsai, Lee-Yea Chuang, et al.
The Kaohsiung Journal of Medical Sciences|July 25, 2016
The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseasesYi-Hung Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of Gastroenterology and Hepatology|February 22, 2011
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infectionJee-Fu Huang, Chung-Feng Huang, Ming-Lung Yu, et al.
Pageof 53

Showing results (201-210 of 527) with videos related to

Sort By:
Pageof 53
Antiviral Therapy|February 17, 2007
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapyMing-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
Journal of Gastroenterology and Hepatology|March 23, 2007
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patientsLi-Po Lee, Chia-Yen Dai, Wan-Long Chuang, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre studyChia-Yen Dai, Tai-Chung Tseng, Grace Lai Hung Wong, et al.
Journal of Hepatology|December 26, 2009
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in TaiwanChia-Yen Dai, Chi-Kung Ho, Jee-Fu Huang, et al.
Scandinavian Journal of Infectious Diseases|April 11, 2009
Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNAYa-Yun Lin, Jee-Fu Huang, Shu-Fen Liu, et al.
JAMA Network Open|August 17, 2023
Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver DiseaseHuiyul Park, Eileen L Yoon, Takanori Ito, et al.
The Lancet. Gastroenterology & Hepatology|January 27, 2018
Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysisMarcus M Mücke, Lisa I Backus, Victoria T Mücke, et al.
Medicine|November 14, 2009
Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinomaJen-Eing Jeng, Huey-Ru Tsai, Lee-Yea Chuang, et al.
The Kaohsiung Journal of Medical Sciences|July 25, 2016
The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseasesYi-Hung Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of Gastroenterology and Hepatology|February 22, 2011
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infectionJee-Fu Huang, Chung-Feng Huang, Ming-Lung Yu, et al.
Pageof 53